Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology.
Fellows have made, and may continue to make, substantial contributions to the disciplines of pharmacology, clinical pharmacology and therapeutics, through their work, publication and presentation of research, leadership, and contribution to Society life.
Find out more and apply for Fellowship.
This directory has been created to increase the visibility of our Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Fellows with similar areas of interest.
Here you can find profiles of each Fellow, including information on their institutional affiliation, year elected, primary professional setting, affinity group membership, and a short biography.
Select the magnifying glass icon to begin any searches.
Professor Nicholas Barnes has been a member of the Faculty of the University of Birmingham Medical School since 1991 and holds the Chair in Neuropharmacology.
I am a Reader in neuropharmacology in the Institute of Ageing and Chronic Diseases, University of Liverpool where I am research Theme lead for Physiological and Systems Approaches to Ageing and teach pharmacology, primarily to veterinary students.
Gary is Professor of Pharmacology and Head of the School of Pharmacy and Pharmaceutical Science at Cardiff University.
Professor Baydoun obtained a BSc(Hons) and PhD in Pharmacology from the University of Sunderland and was a British Heart Foundation Intermediate Fellow at King’s College London before joining the University of Hertfordshire where he is currently the Associate Dean for Research in the School of Life and Medical Sciences and an Associate Director of the Doctoral College.
Evan Begg is an Emeritus Professor at University of Otago’s Christchurch School of Medicine, in NZ He graduated from the University of Auckland in 1974.
Dr Bell received his PhD in Cardiovascular Pharmacology from QUB, investigating regulation of myocardial contractility by cardioendocrine peptides.
Lynne Bollington is the lead consultant for the Prescribing Safety Assessment (PSA) and the Editor-in-Chief of BPS Assessment Ltd.
Alan Boobis is Professor of Biochemical Pharmacology at Imperial College London.